Cortical dysplasia: An immunocytochemical study of three patients

Neurology

Volumn 50, Issue 1, 1998, Pages

  Spreafico, R ^a   Battaglia, G ^a   Arcelli, P ^a   Andermann, F ^b   Dubeau, F ^b   Palmini, A ^c   Olivier, A ^b   Villemure, J G ^b   Tampieri, D ^b   Avanzini, G ^a   Avoli, M ^b  

^a DEPARTMENT OF NEUROSURGERY   (Italy)

^b MCGILL UNIVERSITY   (Canada)

^c Hospital Sao Lucas de UCRS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM BINDING PROTEIN;

ADOLESCENT; ADULT; ARTICLE; BRAIN CORTEX; CASE REPORT; CYTOARCHITECTURE; CYTOSKELETON; DYSPLASIA; FOCAL EPILEPSY; GABAERGIC TRANSMISSION; HUMAN; IMMUNOCYTOCHEMISTRY; INTERNEURON; INTRACTABLE EPILEPSY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL;

EID: 0344653617     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/wnl.50.1.27     Document Type: Article

References (45)

1. Commission on Classification and Terminology of the International League against Epilepsy. Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 1989;30: 389-399.
2. Palmini A, Andermann F, Olivier A, et al. Focal neuronal migration disorders and intractable partial epilepsy: a study of 30 patients. Ann Neurol 1991;30:741-749.
3. Barkovich AJ, Kjos BO. Nonlissencephalic cortical dysplasias: correlation of imaging findings with clinical deficits. AJNR Am J Neuroradiol 1992;13:95-103.
4. Dubeau F, Tampieri D, Lee N, et al. Periventricular and subcortical nodular heterotopia. A study of 33 patients. Brain 1995;118:1273-1287.
5. Kuzniecky R, Morawetz R, Faught E, Black L. Frontal and central lobe focal dysplasia: clinical, EEG and imaging features. Dev Med Child Neurol 1995;37:159-166.
6. Palmini A, Gambardella A, Andermann F, et al. Operative strategies for patients with cortical dysplastic lesions and intractable epilepsy. Epilepsia 1994;35(suppl 6):S57-S71.
7. Fried I, Cascino G. Lesional surgery. In: Engel J Jr, ed. Surgical treatment of the epilepsies. 2nd ed. New York: Raven Press, 1993:501-509.
8. Farrell MA, De Rosa MJ, Curran JG, et al. Neuropathologic findings in cortical resections (including hemispherectomies) performed for the treatment of intractable childhood epilepsy. Acta Neuropathol 1992;83:246-259.
9. Hardiman O, Burke T, Phillips J, et al. Microdysgenesis in resected temporal neocortex: incidence and clinical significance in focal epilepsy. Neurology 1988;38:1041-1047.
10. Meencke HJ, Janz D. The significance of microdysgenesia in primary generalized epilepsy: an answer to the considerations of Lyon and Gastaut. Epilepsia 1985;26:368-371.
11. Meencke HJ, Veith G. Migration disturbance in epilepsy. In: Engel J Jr, Wasterlain C, Cavalheiro EA, Heinemann U, Avanzini G, eds. Molecular neurobiology of epilepsy. Amsterdam: Elsevier, 1992:31-40.
12. Spreafico R, Arcelli P, Dubeau F, et al. Morphological and functional characteristics of human dysplastic cortex [abstract]. Epilepsia 1995;36(suppl 4):28.
13. Duong T, De Rosa MJ, Poukens V, Vinters HV, Fisher RS. Neuronal cytoskeletal abnormalities in human cerebral cortical dysplasia. Acta Neuropathol 1994;87:493-503.
14. Glezer II, Hof PR, Morgane PJ. Calretinin-immunoreactive neurons in the primary visual cortex of dolphin and human brains. Brain Res 1992;595:181-188.
15. Huntley GW, Vickers JC, Janssen W, Brose N, Heinemann SF, Morrison JH. Distribution and synaptic localization of immunocytochemically identified NMDA receptor subunit proteins in sensory-motor and visual cortices of monkey and human. J Neurosci 1994;14:3603-3619.
16. De Felipe J, Huntley GW, del Rio MR, Sola RG, Morrison JH. Microzonal decreases in the immunostaining for non-NMDA ionotropic excitatory amino acid receptors subunits GluR 2/3 and GluR 5/6/7 in the human epileptogenic neocortex. Brain Res 1994;657:150-158.
17. Frassoni C, Bentivoglio M, Spreafico R, Sànchez MP, Puelles L, Fairen A. Postnatal development of calbindin and parvalbumin immunoreactivity in the thalamus of the rat. Dev Brain Res 1991;58:243-249.
18. Spreafico R, Frassoni C, Arcelli P, Battaglia G, Wenthold RJ, De Biasi S. Distribution of AMPA selective glutamate receptors in the thalamus of adult rats and during postnatal development. A light and ultrastructural immunocytochemical study. Dev Brain Res 1994;82:231-244.
19. Meyer G, Wahle P, Castaneyra-Perdomo A, Ferres-Torres R. Morphology of neurons in the white matter of the adult human neocortex. Exp Brain Res 1992;88:204-212.
20. Blümcke I, Hof PR, Morrison JH, Celio MR. Distribution of parvalbumin immunoreactivity in the visual cortex of old world monkeys and humans. J Comp Neurol 1990;301:417-432.
21. Ferrer I, Tunon T, Soriano E, et al. Calbindin immunoreactivity in normal human temporal neocortex. Brain Res 1992;572: 33-41.
22. Del Rio MR, De Felipe J. A study of SMI 32-stained pyramidal cells, parvalbumin-immunoreactive chandelier cells, and presumptive thalamocortical axons in the human temporal neocortex. J Comp Neurol 1994;342:389-408.
23. Taylor DC, Falconer MA, Bruton CJ, Corsellis JAN. Focal dysplasia of the cerebral cortex in epilepsy. J Neurol Neurosurg Psychiatry 1971;34:369-387.
24. Marin Padilla M. Prenatal development of fibrous (white matter), protoplasmic (gray matter) and layer I astrocytes in the human cerebral cortex: a Golgi study. J Comp Neurol 1995; 357:554-572.
25. Moreland DB, Glasauer FE, Egnatchik JG, Heffner RR, Alker GJ Jr. Focal cortical dysplasia. Case report. J Neurosurg 1988;68:487-490.
26. Bignami A, Palladini G, Zappella M. Unilateral megalencephaly with nerve cell hypertrophy. An anatomical and quantitative histochemical study. Brain Res 1968;9:103-114.
27. Manz HJ, Phillips TM, Rowden G, McCullough DC. Unilateral megalencephaly, cerebral cortical dysplasia, neuronal hypertrophy, and heterotopia: cytomorphometric, fluorometric cytochemical, and biochemical analyses. Acta Neuropathol (Berl) 1979;45:97-103.
28. Mischel PS, Nguyen LP, Vinters HV. Cerebral cortical dysplasia associated with pediatric epilepsy. Review of neuropathologic features and proposal for a grading system. J Neuropathol Exp Neurol 1995;54:137-153.
29. De Rosa MJ, Secor DL, Barsom M, Fisher RS, Vinters HV. Neuropathologic findings in surgically treated hemimegalencephaly: immunohistochemical, morphometric, and ultrastructural study. Acta Neuropathol 1992;84:250-260.
30. Hanaway J, Lee SI, Netsky MG. Pachygyria: relation of findings to modern embryologic concepts. Neurology 1968;18:791-799.
31. Stewart RM, Richmann DP, Caviness VS Jr. Lissencephaly and pachygyria: an architectonic and topographical analysis. Acta Neuropathol (Berl) 1975;31:1-12.
32. Houdou S, Kuruta H, Konomi H, Takashima S. Structure in lissencephaly determined by immunohistochemical staining. Pediatr Neurol 1990;6:402-406.
33. Jellinger R, Rett A. Agyria-pachygyria (lissencephaly syndrome). Neuropediatrie 1976;7:66-91.
34. Ferrer I, Oliver B, Russi A, Casas R, Rivera R. Parvalbumin and calbindin-D28k immunocytochemistry in human neocortical epileptic foci. J Neurol Sci 1994;123:18-25.
35. De Felipe J, Sola RG, Marco P, del Rio MR, Pulido P, Ramon y Cajal S. Selective changes in the microorganization of the human epileptogenic neocortex revealed by parvalbumin immunoreactivity. Cereb Cortex 1993;3:39-48.
36. Marco P, Sola RG, Pulido P, et al. Inhibitory neurons in the human epileptogenic temporal neocortex. An immunocytochemical study. Brain 1996;119:1327-1347.
37. Ribak CE, Hunt CA, Bakay RAE, Oertel WH. A decrease in the number of GABAergic somata is associated with the preferential loss of GABAergic terminals at epileptic foci. Brain Res 1986;363:78-90.
38. Houser CR, Harris AB, Vaughn JE. Time course of the reduction of GABA terminals in a model of focal epilepsy: a glutamic acid decarboxylase immunocytochemical study. Brain Res 1986;383:129-145.
39. Spreafico R, Angelini L, Binelli S, et al. Burst suppression and impairment of neocortical ontogenesis: electroclinical and neuropathologic findings in two infants with early myoclonic encephalopathy. Epilepsia 1993;34:800-808.
40. Mathern GW, Leite JP, Pretorius JK, Quinn B, Peacock WJ, Babb TL. Children with severe epilepsy: evidence of hippocampal neuron losses and aberrant mossy fiber sprouting during postnatal granule cell migration and differentiation. Dev Brain Res 1994;78:70-80.
41. Palmini A, Gambardella A, Andermann F, et al. Intrinsic epileptogenicity of human dysplastic cortex as suggested by corticography and surgical results. Ann Neurol 1995;37:476-487.
42. Mattia D, Olivier A, Avoli M. Seizure-like discharges recorded in human dysplastic neocortex maintained in vitro. Neurology 1995;45:1391-1395.
43. Avoli M. Epileptiform discharges and a synchronous GABA-ergic potential induced by 4-aminopyridine in the rat immature hippocampus. Neurosci Lett 1990;117:93-98.
44. Cherubini E, Gaiarsa JL, Ben-Ari Y. GABA: an excitatory transmitter in early postnatal life. Trends Neurosci 1991;14: 515-519.
45. Battaglia G, Arcelli P, Granata T, et al. Neuronal migration disorders and epilepsy: a morphological analysis of three surgically treated patients. Epilepsy Res 1996;26:49-58.